Related references
Note: Only part of the references are listed.Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition
Junbo Liang et al.
CANCER RESEARCH (2020)
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
Maged Zeineldin et al.
NATURE COMMUNICATIONS (2020)
Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies
Thomas Kent et al.
FRONTIERS IN ONCOLOGY (2020)
Temozolomide therapy for aggressive pituitary tumours - current understanding and future perspectives
Pia Burman et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Telomere length alterations and ATRX/DAXX loss in pituitary adenomas
Christopher M. Heaphy et al.
MODERN PATHOLOGY (2020)
Pituitary Adenoma in Pediatric and Adolescent Populations
Jie Chen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
Driver mutations in USP8 wild-type Cushing's disease
Silviu Sbiera et al.
NEURO-ONCOLOGY (2019)
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Sylvie Job et al.
CLINICAL CANCER RESEARCH (2019)
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Aggressive pituitary tumours and carcinomas: two sides of the same coin?
Jacqueline Trouillas et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Mutant ATRX: uncovering a new therapeutic target for glioma
Santiago Haase et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Identification of Novel Genes Involved in the Pathogenesis of an ACTH-Secreting Pituitary Carcinoma: A Case Report and Literature Review
Fuyou Guo et al.
FRONTIERS IN ONCOLOGY (2018)
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel
Angela Zacher et al.
BRAIN PATHOLOGY (2017)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
S. L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort
Daniel Bengtsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region
Olivera Casar-Borota et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Pituitary Carcinoma in a Patient with an SDHB Mutation
Nicola Tufton et al.
ENDOCRINE PATHOLOGY (2017)
Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
Daniel Bengtsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
MicroRNA involvement in a metastatic non-functioning pituitary carcinoma
Zhenqing Wei et al.
PITUITARY (2015)
Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX
David Clynes et al.
NATURE COMMUNICATIONS (2015)
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein et al.
NATURE COMMUNICATIONS (2015)
Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications
Christian P. Miermeister et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011
Axel Tjornstrand et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas et al.
ACTA NEUROPATHOLOGICA (2013)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
Pituitary Carcinoma with Malignant Growth from First Presentation and Fulminant Clinical Course-Case Report and Review of the Literature
Katarzyna Dudziak et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells
Lee H. Wong et al.
GENOME RESEARCH (2010)
Incidence of Pituitary Adenomas in Northern Finland in 1992-2007
Antti Raappana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
P53 gene mutations in pituitary carcinomas
Yoshinori Tanizaki et al.
ENDOCRINE PATHOLOGY (2007)
Pathohistological classification of pituitary tumors:: 10 years of experience with the German Pituitary Tumor Registry
Wolfgang Saeger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies
YT Xue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gonadotropic pituitary carcinoma:: HER-2/neu expression and gene amplification -: Report of two cases
F Roncaroli et al.
JOURNAL OF NEUROSURGERY (2003)
Share Paper
